Celldex Therapeutics
CLDX
#4316
Rank
โ‚น261.22 B
Marketcap
โ‚น3,328
Share price
3.43%
Change (1 day)
91.94%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น0.18 Billion

According to Celldex Therapeutics's latest financial reports the company's total debt is โ‚น0.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น0.20 B-35.89%
2024-12-31โ‚น0.32 B54.57%
2023-12-31โ‚น0.21 B-36.59%
2022-12-31โ‚น0.33 B47.39%
2021-12-31โ‚น0.22 B-11.06%
2020-12-31โ‚น0.25 B-2.38%
2019-12-31โ‚น0.26 B
2018-12-31N/A-100%
2017-12-31โ‚น0.41 B
2015-12-31โ‚น0.29 B78.72%
2014-12-31โ‚น0.16 B
2013-12-31N/A-100%
2012-12-31โ‚น0.62 B-22.51%
2011-12-31โ‚น0.80 B65.26%
2010-12-31โ‚น0.48 B-24.51%
2009-12-31โ‚น0.64 B6028.7%
2008-12-31โ‚น10.47 M-94.83%
2007-12-31โ‚น0.20 B-1.36%
2006-12-31โ‚น0.20 B118.9%
2005-12-31โ‚น93.93 M1062.98%
2004-12-31โ‚น8.07 M
2000-12-31โ‚น12.81 M-47.65%
1999-12-31โ‚น24.47 M-64.03%
1998-12-31โ‚น68.03 M8.19%
1997-12-31โ‚น62.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚น6.015 T 3,340,046.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.410 T 3,004,250.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น2.381 T 1,322,562.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น10.71 B 5,847.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น4.32 B 2,298.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น62.58 B 34,653.67%๐Ÿ‡บ๐Ÿ‡ธ USA